Loading clinical trials...

Artemisia and Green Tea Extracts for Gastric Mucosal Health | Clinical Trials | Clareo Health

COMPLETEDNA

Artemisia and Green Tea Extracts for Gastric Mucosal Health

Effects of Artemisia and Green Tea Extracts on Promoting Gastric Mucosal Health in Adults With Functional Dyspepsia: A Randomized, Double-blind, Placebo-controlled Clinical Trial

NCT06628804•Pusan National University Yangsan Hospital

View on ClinicalTrials.gov

Summary

This clinical trial aims to determine whether Artemisia and green tea extracts promote gastric mucosal health in adults with functional dyspepsia and to assess its safety. The main questions are: * Does Artemisia and green tea extracts promote gastric mucosal health in participants? * What side effects occur when participants take Artemisia and green tea extracts?

Detailed Description

Researchers will compare Artemisia and green tea extracts to placebo to evaluate their effectiveness in promoting gastric mucosal health. Participants will: * Take Artemisia and green tea extracts or a placebo daily for 8 weeks. * Visit the clinic every 4 weeks for checkups and tests.

Eligibility

Age

19 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Rome IV-based functional dyspepsia-

Exclusion Criteria

•Patients with gastrointestinal symptoms requiring immediate drug treatment.
•Individuals with a history of hypersecretory gastric disorders like Zollinger-Ellison syndrome.
•Individuals who received Helicobacter pylori eradication therapy within 4 weeks prior to the trial.
•Individuals who have taken nonsteroidal anti-inflammatory drugs, steroids, antibiotics, aspirin, antithrombotic agents, or acid suppressants within the last month.
•Individuals with a history of upper gastrointestinal surgery, stricture, bleeding, or procedures like esophageal dilation or mucosal resection within the last year.
•Individuals with gastric ulcers (active or healing), duodenal ulcers (active or healing), reflux esophagitis (LA grade A or higher), or malignant tumors identified within the last 6 months through endoscopy.
•Patients with uncontrolled hypertension (resting BP ≥160/100 mmHg).
•Patients with uncontrolled diabetes (fasting glucose ≥160 mg/dL).
•Individuals with creatinine levels ≥ 2 times the upper limit of normal at the research institution.
•Individuals with aspartate aminotransferase or alanine aminotransferase levels ≥ 2 times the upper limit of normal at the research institution.
+6 more criteria

Locations (1)

Pusan National University Yangsan Hospital

Yangsan, South Korea

Key Dates

Start Date

August 1, 2024

Primary Completion Date

December 30, 2025

Completion Date

December 31, 2025

Last Updated

January 13, 2026

Enrollment

100

ACTUAL participants

Conditions

Functional Dysphonia

Interventions

Artemisia and green tea extracts

DIETARY_SUPPLEMENT

Placebo

DIETARY_SUPPLEMENT

Management of Non-Organic Dysphonia in Adults.

NCT06856785

Functional DysphoniaResonance Tube Voice Therapy+1 more

View study

RECRUITINGNA

Safety and Efficacy of Fecal Microbiota Transplantation

NCT04014413

Crohn DiseaseUlcerative Colitis+25 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 13, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Artemisia and Green Tea Extracts for Gastric Mucosal Health

Inclusion Criteria

Exclusion Criteria

Management of Non-Organic Dysphonia in Adults.

Safety and Efficacy of Fecal Microbiota Transplantation

Assessment on Effects of Tongjiang Granule in Treating Nonerosive Reflux Disease Overlapping Epigastric Pain Syndrome

The Effects of Voice Therapy Based on the Estill Voice Model: a Feasibility Study